Optiscan has been featured in The Brisbane Times, The Sydney Morning Herald, The Age, and Bulls N’ Bears following the announcement of a landmark five-year collaboration with US-based Long Grove Pharmaceuticals.

The article highlights how the agreement secures a supply of AK-FLUOR®, Long Grove’s FDA-approved fluorescein sodium contrast dye, for use in Optiscan’s InVue™ imaging system across upcoming clinical studies—starting with breast surgery. The collaboration aims to accelerate FDA submissions and unlock broader applications across gastrointestinal endoscopy, robotic-assisted surgery, and laparoscopic procedures.

“The agreement gives us a supply of Long Grove’s AK-FLUOR®, which will be used in combination with our fluorescence-based endomicroscopic imaging devices to undertake studies and clinical trials. The data flowing from these studies will be an invaluable resource for our regulatory submissions,” Dr. Camile Farah, Optiscan CEO.

The Brisbane Times – Read the full article here
The Sydney Morning Herald – Read the full article here
The Age – Read the full article here
Bulls N’ Bears – Read the full article here